Who
Patricia Paola Gonzalez
Director
Company insider
Files Form 4 as: Director, Abbott Laboratories.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Sep 2021
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K333 at $98.83 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K363 at $90.74 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K363 at $90.74 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K321 at $102.67 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K321 at $102.67 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K263 at $125.29 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K263 at $125.29 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K246 at $133.94 | filing |
| 30 Jun 2025filed 1 Jul 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K242 at $136.01 | filing |
| 25 Apr 2025filed 29 Apr 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —1,635 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K248 at $132.65 | filing |
| 31 Dec 2024filed 3 Jan 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K291 at $113.11 | filing |
| 30 Sep 2024filed 1 Oct 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K289 at $114.01 | filing |
| 30 Jun 2024filed 2 Jul 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K317 at $103.91 | filing |
| 26 Apr 2024filed 30 Apr 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —1,866 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K290 at $113.66 | filing |
| 31 Dec 2023filed 3 Jan 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K299 at $110.07 | filing |
| 30 Sep 2023filed 3 Oct 2023 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $33K340 at $96.85 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.